Navigation Links
Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimer's Vaccine in 19 Countries
Date:9/19/2007

he symptoms of the disease, but there are no drugs on the market today that slow or arrest the progression of the disease. These symptomatic drugs are projected to generate approximately $4 billion in sales by 2008, indicating both the size of the market and the demand for effective treatment beyond symptomatic improvements.

About Intellect Neurosciences, Inc.

Intellect Neurosciences, Inc. is a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease and related disorders. The company has a broad proprietary immunotherapy platform for both active immunization and passive (using humanized monoclonal antibodies) against Alzheimer's disease. Also, Intellect has recently completed Phase I clinical trials for OXIGON(TM), a unique antioxidant and anti-amyloid compound that has potential to treat Alzheimer's disease and other disorders.

For additional information, please visit http://www.intellectns.com .


'/>"/>
SOURCE Intellect Neurosciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related biology technology :

1. Inline intellectual property raises legal issues
2. Intellectual Property: Are you an infringer?
3. Starting a tech business? Step 1 is minding the intellectual property
4. Protect your intellectual property before its too late
5. Protecting your intellectual property in overseas markets
6. Bioanalytical Method Intraday Validation for the Quantitation of Paroxetine in Bovine Plasma using the TSQ Quantum Mass Spectrometer
7. Correlation of Bio-Plex Suspension Array Reader Validation With Multiplex Cytokine Assay Performance, Rev A
8. Development of a sensitive enzyme fragment complementation assay for cyclic adenosine 3, 5 monophosphate and its validation for pharmacological screening at G protein-coupled receptors
9. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
10. Mirus granted European patent for gene therapy
11. Info security group announces first Eastern European chapter

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX...rapy, and a provider of technical and regulatory c...ogy and pharmaceutical companies, today announced ...lders. ,, At the meeting, shareholders of Spher...wing members to the Board of Directors: ,, Dou...
(Date:11/19/2009)...nthesis Companies Form International Gene Synthesi...n Risk Reduction ,Five Member Companies Represen... , (PRWEB) November 19, 20...esis companies today announced agreement that they... biosecurity in the gene synthesis industry. By s...
(Date:11/18/2009)...ind explosive materials and persons who have been ...tional Institute of Standards and Technology (NIST...curity, has developed a new certified reference ma...ace Particulate Explosives. Compatible with field ...ful in calibrating, testing and developing standar...
(Date:11/18/2009)...e-FirstCall/ -- Masimo (Nasdaq: MASI ), the inv... Motion and Low-Perfusion pulse oximetry, announce...he largest healthcare Group Purchasing Organizatio...sing agreement for "gold standard" Masimo SET ...ed contract pricing to Uni.H.A.,s 53 member hospit...
Breaking Biology Technology:Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4New NIST trace explosives standard slated for homeland security duty 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 2Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 3Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products 4
...stCall/ - Vasogen Inc.,(NASDAQ: VSGN ; TSX:VAS) to...estructuring plans to further reduce its cash burn...en exploring strategic alternatives that may,inclu...ion with this,process, the Company has also comple... and has determined that it is in the best interes...
...rsey, July 3, Rosetta Genomics Ltd (Nasdaq: ROSG ...cs and therapeutics, announced today,it will prese... on,Wednesday, July 9, at 8:30 am EST at the Manda...nomics, Rosetta Genomics (Nasdaq: ROSG ) is a le...e company,s integrative research platform combinin...
...eutics, a,specialist in antibiotics development, a...nted as Chief Executive Officer of the Company., ...ars of industry,experience serving most recently a... & Strategy for the oncology business unit at Nova...full array of business development,activities lead...
Other Biology Technology:Vasogen Provides Corporate Update 2Nabriva Therapeutics Announces Appointment of New CEO 2
(Date:11/19/2009)...ller, University of Cincinnati professor of paleon... and co-author Michael Foote of the University of ...e of Science with their paper, "Epicontinental S...ss Extinction and Origination." , For many years...story of biodiversity have focused on charting the...
(Date:11/19/2009)... Jaffrey Receives Competitive NIH Director,s T-R01...low in the Dark , Dr. Samie Jaffrey, associate p...College, is among the first researchers to win a p... from the National Institutes of Health. Dr. Jaffr...otein recognition technologies that may some day s...
(Date:11/19/2009)...RK, Md.-John Fisher, associate professor in the Fi...Inventor Pitch at the 2009 Bioscience Research and...ioreactor system that grows bone and other types o... was one of six innovations presented in an eight ...nts at the Professor Venture Fair, held November 1...
Breaking Biology News(10 mins):Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Weill Cornell science briefs: November 2009 2Weill Cornell science briefs: November 2009 3Weill Cornell science briefs: November 2009 4Weill Cornell science briefs: November 2009 5Bioreactor for bone tissue engineering wins professor venture fair 2Bioreactor for bone tissue engineering wins professor venture fair 3Recent smoking cessation research highlights importance of keeping teens from smoking 47789 1Recent smoking cessation research highlights importance of keeping teens from smoking 47789 2Single women gaze longer 8706 1Single women gaze longer 8706 2GHX Announces 2009 Best In Class Award Winners 47786 1GHX Announces 2009 Best In Class Award Winners 47786 2GHX Announces 2009 Best In Class Award Winners 47786 3GHX Announces 2009 Best In Class Award Winners 47786 4
...first four-legged animals sprouted fingers and toe...extended the cooking time, say University of Flori...ournal PLoS ONE. , Even sharks which have exis...cipe for fingers in their genetic cookbook not to...e mechanisms of development in shark embryos, UF s...
...2+ Oscillations and Neurite Growth ,Kazunori Ka...ino , This week, Kanemaru et al. explore the sign...ons in cultured astrocytes and the promotion of ne...membrane-bound adhesion molecule N-cadherin. The a...P 3 signaling with retroviral-mediated expression...
... who eat a diet high in red meat, fatty products, ...diet may be increasing their chance of disease re...Farber Cancer Institute. , The study, published i... Medical Association, involved 1,009 patients with... both surgery and chemotherapy. Stage III colon ca...
Other Biology News:Conquest of land began in shark genome 2Conquest of land began in shark genome 3News tips from the Journal of Neuroscience 2News tips from the Journal of Neuroscience 3'Western' diet linked to increased risk of colon cancer recurrence 2
Direct ELISA Assay Diluent from BioFX Laboratories, Inc.
Direct ELISA Assay Diluent - EDTA from BioFX Laboratories, Inc.
Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen
Fluorescence Preserving Media from BioFX Laboratories, Inc.
Biology Products: